Forskning
Udskriv Udskriv
Switch language
  1. Rigshospitalet
  2. Forskere
  3. Kristoffer Staal Rohrberg
Rigshospitalet - en del af Københavns Universitetshospital

Kristoffer Staal Rohrberg

Seneste publikationer Vis alle (13) »

  1. Udgivet

    Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2. Udgivet

    Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3. Udgivet

    Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Mest brugte tidsskrifter Vis alle »

  1. Acta Oncologica

    ISSN'er: 0284-186X, 0349-652X, 0348-5196, 0567-8064, 0284-186x

    Yderligere søgbare ISSNs (Elektroniske): 1651-226X

    Informa Healthcare, Storbritannien

    Tidsskrift

  2. Oncotarget

    ISSN'er: 1949-2553

    Impact Journals LLC, USA

    Tidsskrift

  3. Journal of Clinical Oncology

    ISSN'er: 0732-183X, 1527-7755

    American Society of Clinical Oncology, USA

    Tidsskrift

  4. Clinical Cancer Research

    ISSN'er: 1078-0432

    Yderligere søgbare ISSNs (Elektroniske): 1557-3265

    American Association for Cancer Research (A A C R), USA

    Tidsskrift

  5. Cytotherapy

    ISSN'er: 1465-3249

    Yderligere søgbare ISSNs (Elektroniske): 1477-2566

    Informa Healthcare, Storbritannien

    Tidsskrift

Vis graf over relationer

Expertise

Clinical oncology; Early clinical trials; Translational oncology; personalized medicin;

Primære forskningsområder

Phase 1 oncology trails; Early Phase 2 oncology trials; Translational medicin; Personalized medicin; Patient derived xenografts; Cancer drug screening

Aktuel forskning

Phase 1 clinical trials and early phase 2 clinical trials.

Creation of PDX for cancer drug screening and application of the findings in patients.

Mulige interessekonflikter

None

ID: 32263813